FLAG-Ida regimen

WikiDoc Resources for FLAG-Ida regimen

Articles

Most recent articles on FLAG-Ida regimen

Most cited articles on FLAG-Ida regimen

Review articles on FLAG-Ida regimen

Articles on FLAG-Ida regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on FLAG-Ida regimen

Images of FLAG-Ida regimen

Photos of FLAG-Ida regimen

Podcasts & MP3s on FLAG-Ida regimen

Videos on FLAG-Ida regimen

Evidence Based Medicine

Cochrane Collaboration on FLAG-Ida regimen

Bandolier on FLAG-Ida regimen

TRIP on FLAG-Ida regimen

Clinical Trials

Ongoing Trials on FLAG-Ida regimen at Clinical Trials.gov

Trial results on FLAG-Ida regimen

Clinical Trials on FLAG-Ida regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on FLAG-Ida regimen

NICE Guidance on FLAG-Ida regimen

NHS PRODIGY Guidance

FDA on FLAG-Ida regimen

CDC on FLAG-Ida regimen

Books

Books on FLAG-Ida regimen

News

FLAG-Ida regimen in the news

Be alerted to news on FLAG-Ida regimen

News trends on FLAG-Ida regimen

Commentary

Blogs on FLAG-Ida regimen

Definitions

Definitions of FLAG-Ida regimen

Patient Resources / Community

Patient resources on FLAG-Ida regimen

Discussion groups on FLAG-Ida regimen

Patient Handouts on FLAG-Ida regimen

Directions to Hospitals Treating FLAG-Ida regimen

Risk calculators and risk factors for FLAG-Ida regimen

Healthcare Provider Resources

Symptoms of FLAG-Ida regimen

Causes & Risk Factors for FLAG-Ida regimen

Diagnostic studies for FLAG-Ida regimen

Treatment of FLAG-Ida regimen

Continuing Medical Education (CME)

CME Programs on FLAG-Ida regimen

International

FLAG-Ida regimen en Espanol

FLAG-Ida regimen en Francais

Business

FLAG-Ida regimen in the Marketplace

Patents on FLAG-Ida regimen

Experimental / Informatics

List of terms related to FLAG-Ida regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: IDA-FLAG Regimen; Idarubicin-Fludarabine-AraC/G-CSF Regimen

## Overview[edit | edit source]

FLAG-Ida regimen refers to idarubicin, fludarabine, high-dose cytarabine (AraC) and filgrastim (G-CSF), used as a remission-induction treatment for for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia.[1]

## Regimen[edit | edit source]

IDAIdarubicin

FLFludarabine

ACytarabine (AraC)

GFilgrastim (G-CSF)

## Indications[edit | edit source]

* Poor-risk myelodysplastic syndromes and acute myeloid leukaemia.[1]

## References[edit | edit source]

1. ↑ 1.0 1.1 Parker JE, Pagliuca A, Mijovic A, Cullis JO, Czepulkowski B, Rassam SM; et al. (1997). "Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia". Br J Haematol. 99 (4): 939–44. PMID 9432047.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)